Weekly Finstrology Update for June 26: Trading Week Bookends

Two potentially interesting dates book-end this week’s trading. The first is Monday, June 26, which author Christopher Carolan identified in his 1992 book, “The Spiral Calendar,” as a stock market top related mathematically by lunar cycle to those in 1929 and 1987, each of which preceded significant market crashes. The second is Friday, June 30, when Jupiter enters 09 Taurus for six days, the same degree that contained the 2011 debt crisis and subsequent U.S. credit downgrade. So, our recent debt crisis could be back in the news then.

Mercury began a two-week stint in out-of-bounds territory over the weekend, so the trading and stock indexes it rules could behave in unexpected ways through July 7. Mercury squares Neptune on Sunday night, so interpreting data or trading activity could be fuzzy as the week begins. A second hard aspect—Mars square Uranus—only adds to the potential for a difficult, uncertain trading day. Mercury leaves its ruling sign of Gemini to enter Cancer on Monday night, when protecting trade (generally) or your own trading increases in importance. 

On Wednesday, the S&P 500 could make a high as Mercury and the sun form a grand trine with the market’s natal Venus/Mercury conjunction and Neptune. Explosive Uranus is partile conjunct natal Mars, with Venus and Mars square, adding to the potential for volatility. The June 16 high at 4448 looks to provide significant resistance. 

The sun and Mercury in Cancer trine Saturn in Pisces late in the week. The trine is an easy aspect, so it supports the ability to identify and communicate about long-term plans. That task is even better suited to reviewing previous plans because Saturn in retrograde. Thus, Thursday’s reports on GDP and unemployment can be evaluated with a long-term lens.

Markets on the Move

NVO | Novo Nordisk A/S

Novo Nordisk, the Denmark company that makes the diabetes drug Ozempic, sued several medical spas, weight-loss clinics, and wellness clinics for selling custom-made versions of the drug, which also has been found to be useful in weight loss. Novo Nordisk got its start a century ago to produce and sell insulin and was organized as part of a foundation in order to focus profits on scientific and humanitarian purposes. The foundation maintains a controlling interest in the company. 

The foreign stock trades as an ADR (American Depository Receipt) in the United States, and opened for trading on July 9, 1981 in New York. It recently made an all-time high at $172.97 on April 21, 2023 when the first-trade sun in Cancer was activated by a conjunction from Mars and a sextile from the moon, Mercury and Uranus. Also, transiting sun and Jupiter were opposite the stock’s natal moon/Pluto conjunction in Libra. 

Look for a potential high on Monday, July 3 when the full moon and Mercury are aligned with the first-trade sun. Prices could drop into a low by July 6 when the moon forms a grand trine with the stock’s natal moon, Mercury and Mars as transiting Venus and Mars are sextile natal Mars and Mercury. 
On July 17, prices could peak as the new moon conjoins the first-trade sun and Mercury is exactly aligned with natal Venus. A month later, on August 18, prices could form a low when Mars, Mercury and the moon all square the stock’s first-trade Mars/Mercury conjunction.

Weekly Highlights

• Soybeans Low on Monday, June 26—Transiting Jupiter is exactly aligned with the market’s sensitive Venus/Uranus opposition. In addition, the moon is conjunct natal Mercury while the sun and Mercury are square. Watch $12.98 per bu., basis November futures, for support.

• Gold High on Thursday, June 29—The moon forms a grand trine with gold’s first-trade Jupiter and Saturn while Jupiter trines the market’s natal sun as the sun and Mercury are opposite. In August futures, look for resistance $10 per oz. either side of $2000.

All times Eastern

All information in this post is merely the personal opinion of the author and not that of Astrology.com or any other person, company, or entity. This information is not to be construed as financial advice, nor relied upon as such. Please contact your broker or financial advisor for trading and investment advice, and use astrological indicators in combination with other trading-decision inputs. Past results are not necessarily indicative of future market behavior.